David Buck
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Genetics top 1%
- Genetic Associations and Epidemiology
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Genomics and Rare Diseases
- Genomic variations and chromosomal abnormalities
Papers in
-
- SARS-CoV-2 and COVID-19 Research 18
- Genetics 28
- Genetic Associations and Epidemiology 11
- Genomics and Rare Diseases 8
- Genomic variations and chromosomal abnormalities 8
- Bacterial Genetics and Biotechnology 4
- Co-authors
- Paolo Piazza (10 shared papers)Mariateresa de Cesare (2 shared papers)Rory J. Bowden (7 shared papers)Jason L. Weirather (1 shared paper)Yunhao Wang (1 shared paper)Kin Fai Au (1 shared paper)Vittorio Sebastiano (1 shared paper)Xiu‐Jie Wang (1 shared paper)
- Journals
- Nature (8 papers)Nature Communications (7 papers)Scientific Reports (4 papers)Nature Genetics (3 papers)F1000Research (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
David Buck
71 papers receiving 10.4k citations
David Buck's Hit Papers
Peers
Comparison fields: 5 of 167
- Infectious Diseases 3.8k
- Genetics 2.3k
- Modeling and Simulation 226
- Clinical Biochemistry 171
- Molecular Biology 2.2k
Countries citing papers authored by David Buck
This map shows the geographic impact of David Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Buck more than expected).
Fields of papers citing papers by David Buck
This network shows the impact of papers produced by David Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Buck. The network helps show where David Buck may publish in the future.
Co-authors
The 25 scholars most cited alongside David Buck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The DNA sequence of the human X chromosome Hit paper breakdown → | 2005 | 855 |
| 2 | The genetic architecture of type 2 diabetes Hit paper breakdown → | 2016 | 845 |
| 3 | The DNA sequence of human chromosome 22 Hit paper breakdown → | 1999 | 834 |
| 4 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 814 |
| 5 | 2020 | 756 | |
| 6 | SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Hit paper breakdown → | 2022 | 571 |
| 7 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 530 |
| 8 | Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis Hit paper breakdown → | 2015 | 442 |
| 9 | 2017 | 346 | |
| 10 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 325 |
| 11 | 2015 | 296 | |
| 12 | 2001 | 283 | |
| 13 | 2021 | 273 | |
| 14 | 2015 | 250 | |
| 15 | 2021 | 228 | |
| 16 | 2012 | 226 | |
| 17 | A blood atlas of COVID-19 defines hallmarks of disease severity and specificity Hit paper breakdown → | 2022 | 225 |
| 18 | 2012 | 210 | |
| 19 | 2014 | 143 | |
| 20 | 2019 | 141 |
About David Buck
David Buck is a scholar working on Infectious Diseases, Genetics, Molecular Biology, Modeling and Simulation and Biochemistry, having authored 76 papers that have together received 10.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (18 papers), Genetic Associations and Epidemiology (11 papers), Genomics and Phylogenetic Studies (11 papers), Genomics and Rare Diseases (8 papers), Genomic variations and chromosomal abnormalities (8 papers), Single-cell and spatial transcriptomics (4 papers), Cancer Genomics and Diagnostics (4 papers) and Bacterial Genetics and Biotechnology (4 papers). The work is most often cited by research in Infectious Diseases (3.8k citations), Genetics (2.3k citations), Modeling and Simulation (226 citations), Clinical Biochemistry (171 citations) and Molecular Biology (2.2k citations). David Buck has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paolo Piazza, Mariateresa de Cesare, Rory J. Bowden, Jason L. Weirather, Yunhao Wang, Kin Fai Au, Vittorio Sebastiano, Xiu‐Jie Wang, Moustafa Attar and Rajesh V. Thakker. Their work appears in journals such as Nature, Nature Communications, Scientific Reports, Nature Genetics and F1000Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.